Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q3 FY25 results · Oct–Dec 2024
Unichem Laboratories reported revenue from operations of ₹533.09 crore (up 22.7% from Q3 FY24) and net profit of ₹57.85 crore (down 31.1% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 533.09 | 434.38 | +22.7% | 462.16 | +15.3% |
| Other income | 13.62 | 11.28 | +20.8% | 8.79 | +54.9% |
| Total income | 546.71 | 445.66 | +22.7% | 470.95 | +16.1% |
| Profit before tax | 61.85 | 83.97 | −26.3% | 32.99 | +87.5% |
| Net profit for the period | 57.85 | 83.99 | −31.1% | 30.49 | +89.7% |
| EPS, basic (₹) | 8.22 | 11.93 | −31.1% | 4.34 | +89.4% |
| Net margin (%) | 10.9 | 19.3 | 6.6 |
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 447.83 | 362.43 | +23.6% | 436.88 | +2.5% |
| Other income | 18.93 | 9.94 | +90.4% | 7.08 | +167.4% |
| Total income | 466.76 | 372.37 | +25.3% | 443.96 | +5.1% |
| Profit before tax | 61.80 | 69.30 | −10.8% | 43.37 | +42.5% |
| Net profit for the period | 46.89 | 69.30 | −32.3% | 43.37 | +8.1% |
| EPS, basic (₹) | 6.66 | 9.85 | −32.4% | 6.16 | +8.1% |
| Net margin (%) | 10.5 | 19.1 | 9.9 |
Consolidated
- Filed with BSE
- 06 Feb 2025, 14:03 IST
- Board meeting
- 06 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Feb 2025, 14:03 IST
- Board meeting
- 06 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE